Screening for oropharyngeal dysphagia in adult patients with neuromuscular diseases using the Sydney Swallow Questionnaire.
Sydney Swallow Questionnaire
neuromuscular diseases
oropharyngeal dysphagia
screening
Journal
Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
19
04
2021
received:
11
09
2020
accepted:
20
04
2021
pubmed:
24
4
2021
medline:
22
9
2021
entrez:
23
4
2021
Statut:
ppublish
Résumé
Oropharyngeal dysphagia is common in patients with neuromuscular diseases (NMDs). Its early recognition is vital for proper management. We tested a large cohort of adult NMD patients for oropharyngeal dysphagia using the Sydney Swallow Questionnaire (SSQ). We also looked for possible differences in characteristics of oropharyngeal dysphagia in various NMD groups and diseases. Finally, we compared results of this screening with those from their corresponding medical records for eventual "clinical history" of dysphagia. We asked patients to fill in the SSQ during follow-up outpatient visits at our neuromuscular reference center. A total score above the cutoff score of 118.5 out of 1700 was indicative of oropharyngeal dysphagia. Of the 304 adult patients assessed for eligibility, 201 NMD patients (96 women and 105 men, aged 49.0 ± 16.2 years) were included and tested in this study. Oropharyngeal dysphagia was detected in 45% of all the NMD patients when using the SSQ, whereas only 12% had a positive medical record for dysphagia. The median SSQ scores for patients with myotonic syndromes (including myotonic dystrophy type 1), with amyotrophic lateral sclerosis, and with facioscapulohumeral dystrophy were above the cutoff score. The SSQ scores obtained revealed distinct oropharyngeal dysphagia characteristics in the different NMD groups and diseases. The SSQ tests positively for oropharyngeal dysphagia in a higher proportion of NMD patients compared with their medical records. The distinct oropharyngeal dysphagia characteristics we revealed in different NMD groups and diseases may help to elaborate adapted clinical approaches in the management of oropharyngeal dysphagia.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-284Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Shaker R, Belafsky PC, Postma GN, Easterling C. Principles of Deglutition a Multidisciplinary Text for Swallowing and Its Disorders. New York: Springer; 2013.
Desuter G, ed. Oropharyngeal Dysphagia Videoendoscopy-Guided Work-Up and Management: Videoendoscopy-Guided Work-Up and Management. New York: Springer; 2019.
Saeian K, Shaker R. Oropharyngeal dysphagia. Curr Treat Option Gastroenterol. 2000;3:77-87.
Willig TN, Paulus J, Guily JLS, Beon C, Navarro J. Swallowing problems in neuromuscular disorders. Arch Phys Med Rehabil. 1994;75:1175-1181.
Toussaint M, Davidson Z, Bouvoie V, Evenepoel N, Haan J, Soudon P. Dysphagia in Duchenne muscular dystrophy: practical recommendations to guide management. Disabil Rehabil. 2016;5:1-11.
Knuijt S, Kalf JG, de Swart BJ, et al. Dysarthria and dysphagia are highly prevalent among various types of neuromuscular diseases. Disabil Rehabil. 2014;36:1285-1289.
Aloysius A, Born P, Kinali M, Davis T, Pane M, Mercuri E. Swallowing difficulties in Duchenne muscular dystrophy: indications for feeding assessment and outcome of videofluroscopic swallow studies. Eur J Paediatr Neurol. 2008;12:239-245.
Pane M, Vasta I, Messina S, et al. Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2006;10:231-236.
Britton D, Karam C, Schindler JS. Swallowing and secretion management in neuromuscular disease. Clin Chest Med. 2018;39:449-457.
Verin E, Clavé P, Bonsignore MR, et al. Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases. Eur Respir J. 2017;49:1602530.
Wada A, Kawakami M, Liu M, et al. Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the neuromuscular disease swallowing status scale (NdSSS). J Neurol. 2015;262:2225-2231.
Salera S, Menni F, Moggio M, Guez S, Sciacco M, Esposito S. Nutritional challenges in Duchenne muscular dystrophy. Nutrients. 2017;9:594.
Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest. 2006;130:1879-1886.
Espitalier F, Fanous A, Aviv J, et al. International consensus (ICON) on assessment of oropharyngeal dysphagia. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(Suppl):S17-S21.
Bours GJ, Speyer R, Lemmens J, Limburg M, de Wit R. Bedside screening tests vs. videofluoroscopy or fibreoptic endoscopic evaluation of swallowing to detect dysphagia in patients with neurological disorders: systematic review. J Adv Nurs. 2009;65:477-493.
Wallace KL, Middleton S, Cook IJ. Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology. 2000;118:678-687.
Logemann JA, Veis S, Colangelo L. A screening procedure for oropharyngeal dysphagia. Dysphagia. 1999;14:44-51.
Audag N, Goubau C, Toussaint M, Reychler G. Screening and evaluation tools of dysphagia in adults with neuromuscular diseases: a systematic review. Ther Adv Chronic Dis. 2019;10. https://doi.org/10.1177/2040622318821622.
Holland G, Jayasekeran V, Pendleton N, Horan M, Jones M, Hamdy S. Prevalence and symptom profiling of oropharyngeal dysphagia in a community dwelling of an elderly population: a self-reporting questionnaire survey. Dis Esophagus. 2011;24:476-480.
Archer SK, Garrod R, Hart N, Miller S. Dysphagia in Duchenne muscular dystrophy assessed by validated questionnaire. Int J Lang Commun Disord. 2013;48:240-246.
Arenaz Bua B, Bulow M. Validation in Swedish of Sydney Swallow Questionnaire. BMC Res Notes. 2014;7:742.
Dwivedi RC, St Rose S, Chisholm EJ, et al. Evaluation of swallowing by Sydney Swallow Questionnaire (SSQ) in oral and oropharyngeal cancer patients treated with primary surgery. Dysphagia. 2012;27:491-497.
Szczesniak MM, Maclean J, Zhang T, Liu R, Cook IJ. The normative range for and age and gender effects on the Sydney swallow questionnaire (SSQ). Dysphagia. 2014;29:535-538.
Audag N, Goubau C, Danse E, et al. Validation and reliability of the French version of the Sydney swallow questionnaire. Dysphagia. 2019;34:556-566.
Bonne G, Rivier F, Hamroun D. The 2019 version of the Gene Table of Neuromuscular Disorders (Nuclear Genome). Neuromuscul Disord. 2018;28:1031-1063.
Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763-1768.
Yule GU. On the methods of measuring association between two attributes. J R Stat Soc. 1912;75:579-652.
van den Engel-Hoek L, Erasmus CE, Hendriks JC, et al. Oral muscles are progressively affected in Duchenne muscular dystrophy: implications for dysphagia treatment. J Neurol. 2013;260:1295-1303.
Messina S, Vita GL. Clinical management of Duchenne muscular dystrophy: the state of the art. Neurol Sci. 2018;39:1837-1845.
Lagarde MLJ, van Alfen N, Geurts ACH, de Groot IJM, van den Engel-Hoek L. Orofacial muscles may be affected in early stages of Becker muscular dystrophy: a preliminary study. Muscle Nerve. 2020;61:213-217.
Yamada Y, Kawakami M, Wada A, Otsuka T, Muraoka K, Liu M. A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy. Disabil Rehabil. 2018;40:1421-1425.
Wohlgemuth M, de Swart BJ, Kalf JG, Joosten FB, Van der Vliet AM, Padberg GW. Dysphagia in facioscapulohumeral muscular dystrophy. Neurology. 2006;66:1926-1928.
Mul K, Berggren KN, Sills MY, et al. Effects of weakness of orofacial muscles on swallowing and communication in FSHD. Neurology. 2019;92:e957-e963.
Stubgen JP. Facioscapulohumeral muscular dystrophy: a radiologic and manometric study of the pharynx and esophagus. Dysphagia. 2008;23:341-347.
Andrenelli E, Galli FL, Gesuita R, et al. Swallowing impairments in amyotrophic lateral sclerosis and myotonic dystrophy type 1: looking for the portrait of dysphagic patient in neuromuscular diseases. NeuroRehabilitation. 2018;42:93-102.
Pilz W, Baijens LW, Kremer B. Oropharyngeal dysphagia in myotonic dystrophy type 1: a systematic review. Dysphagia. 2014;29:319-331.
van den Engel-Hoek L, de Groot IJ, de Swart BJ, Erasmus CE. Feeding and swallowing disorders in pediatric neuromuscular diseases: an overview. J Neuromuscul Dis. 2015;2:357-369.
Hamilton MJ, McLean J, Cumming S, et al. Outcome measures for central nervous system evaluation in myotonic dystrophy type 1 may be confounded by deficits in motor function or insight. Front Neurol. 2018;9:780.
Garand KL, Schwertner R, Chen A, Pearson WG Jr. Computational analysis of pharyngeal swallowing mechanics in patients with motor neuron disease: a pilot investigation. Dysphagia. 2018;33:243-250.
Waito AA, Valenzano TJ, Peladeau-Pigeon M, Steele CM. Trends in research literature describing dysphagia in motor neuron diseases (MND): a scoping review. Dysphagia. 2017;32:734-747.
Andersen TM, Sandnes A, Fondenes O, et al. Laryngeal responses to mechanically assisted cough in progressing amyotrophic lateral sclerosis. Respir Care. 2018;63:538-549.
Hadjikoutis S, Wiles CM, Eccles R. Cough in motor neuron disease: a review of mechanisms. Q J Med. 1999;92:487-494.
Romero-Gangonells E, Virgili-Casas MN, Dominguez-Rubio R, et al. Evaluation of dysphagia in motor neuron disease. Review of available diagnostic tools and new perspectives. Dysphagia. 2020. doi: https://doi.org/10.1007/s00455-020-10170-7.
Paris G, Martinaud O, Hannequin D, et al. Clinical screening of oropharyngeal dysphagia in patients with ALS. Ann Phys Rehabil Med. 2012;55:601-608.
Onesti E, Schettino I, Gori MC, et al. Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management. Front Neurol. 2017;8:94-94.
Benson B, Sulica L, Guss J, Blitzer A. Laryngeal neuropathy of Charcot-Marie-Tooth disease: further observations and novel mutations associated with vocal fold paresis. Laryngoscope. 2010;120:291-296.
Cordeiro JL, Marques W, Hallak JE, Osorio FL. Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review. ASN Neurol. 2014;6:185-192.
Soderholm S, Lehtinen A, Valtonen K, Ylinen A. Dysphagia and dysphonia among persons with post-polio syndrome-a challenge in neurorehabilitation. Acta Neurol Scand. 2010;122:343-349.
Sonies BC, Dalakas MC. Dysphagia in patients with the post-polio syndrome. N Engl J Med. 1991;324:1162-1167.
Li Hi Shing S, Chipika RH, Finegan E, Murray D, Hardiman O, Bede P. Post-polio syndrome: more than just a lower motor neuron disease. Front Neurol. 2019;10:773-773.
Buchholz DW, Jones B. Post-polio dysphagia: alarm or caution? Orthopedics. 1991;14:1303-1305.
Sonies BC. Dysphagia and post-polio syndrome: past, present, and future. Semin Neurol. 1996;16:365-370.
Roy AJ, Van den Bergh P, Van Damme P, Doggen K, Van Casteren V. Early stages of building a rare disease registry, methods and 2010 data from the Belgian neuromuscular disease registry (BNMDR). Acta Neurol Belg. 2015;115:97-104.